Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Falzon, M. Zignol, C. Sismanidis, P. Glaziou (Geneva, Switzerland). Is multidrug-resistant TB more common in children? An analysis of surveillance data. Eur Respir J 2012; 40: Suppl. 56, 203

Member's Comments

No comment yet.

Related content which might interest you: Multidrug-resistant tuberculosis in children: evidence from global surveillance Source: Eur Respir J 2013; 42: 701-707 Year: 2013 Towards elimination of childhood and adolescent tuberculosis in the Netherlands: an epidemiological time-series analysis of national surveillance data Source: Eur Respir J, 56 (4) 2001086; 10.1183/13993003.01086-2020 Year: 2020 Surgical treatment for MDR TB patients – preliminary results from a Romanian MDR TB centre Source: Eur Respir J 2006; 28: Suppl. 50, 276s Year: 2006 Is multidrug-resistant tuberculosis on the rise in Mozambique? Results of a national drug resistance survey Source: Eur Respir J 2011; 37: 222-224 Year: 2011 Getting the best possible evidence from observational studies of treatment of multidrug-resistant tuberculosis patients Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013 Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk Source: Eur Respir J 2012; 39: 1425-1431 Year: 2012 Molecular epidemiological analysis of cases of pulmonary tuberculosis in patients with multiple admissions to TB hospital Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016 The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results Source: Eur Respir J 2011; 38: 1374-1381 Year: 2011 The clinical features and treatment of cases with MDR TB of adolescents Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007 Non-tuberculous mycobacterial disease in patients who were referred as MDR-TB in resource limited settings: need for more rapid identification Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008 HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 A multicentric cohort analysis of culture conversion and reversion in multidrug resistant tuberculosis (MDRTB) patients Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013 Widespread use of serological tests for tuberculosis: data from 22 high-burden countries Source: Eur Respir J 2012; 39: 502-505 Year: 2012 Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts. Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country Source: Eur Respir J, 57 (6) 2002544; 10.1183/13993003.02544-2020 Year: 2021 Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline Source: Eur Respir J , 49 (3) 1700146; DOI: 10.1183/13993003.00146-2017 Year: 2017 Which is the level of education among TB and MDR TB patients about their disease? A patient‘s questionnaire Source: Eur Respir J 2006; 28: Suppl. 50, 588s Year: 2006 Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence Source: Eur Respir J 2016; 47: 394-402 Year: 2016 Multi-drug resistant tuberculosis: a retrospective analysis of cases over 10 years in a low incidence setting Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007